SCIOTEQ
15.2.2024 12:01:28 CET | Business Wire | Press release
ScioTeq, a leading provider of mission-critical defense and avionics visualization and computing solutions, announces the establishment in Bangalore, India of ScioTeq Pvt Ltd, a wholly owned subsidiary of ScioTeq bv. This move will further extend ScioTeq’s global presence by providing Sales, Procurement and Services at its Bangalore location. Additionally, by joining with local partners it will position ScioTeq to support local trade sales and manufacturing of its products and solutions for the Defense market.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240215830655/en/
ScioTeq Group Worldwide Locations. (Photo: Business Wire)
This move aligns with the “Make in India” initiative of the Government of India to create and encourage companies to develop, manufacture and assemble products made in India and incentivize dedicated investments into manufacturing. The policy creates a conducive environment for business investment, while building a modern structure and opening new sectors for capital investment. It also creates additional jobs that align with the government’s mantra “Atmanirbhar Bharat” (Self Reliant India) which is focused on promoting indigenization in the Defense sector.
“ScioTeq is excited to evolve our long-term relationship with India’s defense community to the next level with this newly established subsidiary,” said ScioTeq Vice President of Defense & Security, Klaas Peerlinck. “It confirms our commitment as a partner in India’s defense manufacturing establishment as well as providing a base to provide dedicated service and sales needs.”
India’s Defense budget is the fourth largest in the world thus providing various opportunities for Defense industries to engage and partner with them as they develop and upgrade their military capabilities. ScioTeq, the largest independent advanced visualization company globally, has engaged with the Indian defense establishment for over two decades, providing critical visualization solutions. This long-term experience in the country, robust portfolio of visualization and computing displays and now a local base of operations, amply positions ScioTeq for future growth and provides the Indian Defense sector with visualization and computing solutions across all three of its services - the Navy, Army, and Air Force.
“We welcome the move by ScioTeq in incorporating a wholly owned subsidiary in India to drive indigenous manufacturing of their products. We value our association and look forward to working with them,” said Mr. Arun Ramchandani, Head of Larsen & Toubro Defence (L&T). L&T is a multinational Indian conglomerate engaged in various industry sectors including defense.
About ScioTeq
ScioTeq has 35+ years’ experience designing, engineering and manufacturing high-tech, innovative, life- and mission-critical computing & visualization solutions for the Air Traffic Control, Avionics and Defense & Security markets. With headquarters in Belgium and five additional locations worldwide, they are a trusted partner in advanced computing & visualization solutions. ScioTeq products are used in the air, on the ground and at sea, delivering mission-critical information to operators on some of the most advanced platforms on the planet and in some of the most challenging environments.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240215830655/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 22:42:00 CET | Press release
- Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) is the first systemic treatment for adult patients with advanced SCAC in Europe- The EC approval is based on results of the POD1UM-303 study which showed that adult patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment compared to chemotherapy alone.1 Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meur
Dfns Launches Payouts6.3.2026 21:27:00 CET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 20:23:00 CET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 18:30:00 CET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
Sutherland Launches FinAI Hub to Industrialize Agentic AI for Banking and Financial Services6.3.2026 14:00:00 CET | Press release
A domain-trained AI agent workforce enables production-scale AI across regulated financial institution operations Today, Sutherland announced the launch of Sutherland FinAI Hub, an enterprise Agentic AI platform built exclusively for Banking and Financial Services. As financial institutions accelerate AI adoption, many initiatives remain confined to pilots, unable to scale across legacy systems and core operations. Sutherland FinAI Hub is designed to help close that gap. FinAI Hub is an innovation ecosystem where Sutherland works with clients to design, prototype, and scale Agentic AI workflows across core operations. At launch, the platform brings together a large and expanding workforce of domain-trained AI agents purpose-built for financial institutions, supporting functions across retail banking, payments, cards, consumer and commercial lending, servicing, back office, risk and compliance functions. These modular agents can operate independently or be orchestrated across end-to-end
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom